Premium
ChrysCapital has sold another chunk of its stake in a Mumbai-based drugmaker, as the homegrown private equity firm positions itself...
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.